Spain · AEMPS CIMA
AMOXICILINA / ACIDO CLAVULANICO SANDOZ 250 mg/62,5 mg/5 ml POLVO PARA SUSPENSION ORAL EFG
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62800
- Form
- POLVO PARA SUSPENSIÓN ORAL
- Composition / generic term
- amoxicilina + ácido clavulánico
- Source strength
- 250 mg amoxicilina/62,5 mg acido clavulanico
- Authorisation holder
- Sandoz Farmaceutica S.A.
- Marketed in source snapshot
- Yes
Source-listed ingredients
- AMOXICILINA TRIHIDRATO — 287 mg
- CLAVULANATO POTASIO — 86 mg
These values do not establish equivalence or a dose recommendation.
Packages
- AMOXICILINA / ACIDO CLAVULANICO SANDOZ 250 mg/62,5 mg/5 ml POLVO PARA SUSPENSION ORAL EFG, 1 frasco de 100 ml
- AMOXICILINA / ACIDO CLAVULANICO SANDOZ 250 mg/62,5 mg/5 ml POLVO PARA SUSPENSION ORAL EFG, 1 frasco de 120 ml
- AMOXICILINA / ACIDO CLAVULANICO SANDOZ 250 mg/62,5 mg/5 ml POLVO PARA SUSPENSION ORAL EFG, 1 frasco de 80 ml
Source and coverage
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →